Skip to main content
Top
Published in: Journal of Cancer Survivorship 2/2014

01-06-2014

The integration of cancer survivorship training in the curriculum of hematology/oncology fellows and radiation oncology residents

Authors: Michelle Shayne, Eva Culakova, Michael T. Milano, Sughosh Dhakal, Louis S. Constine

Published in: Journal of Cancer Survivorship | Issue 2/2014

Login to get access

Abstract

Background

Cancer specialists require an understanding of survivors' needs to insure optimal delivery of care. Training programs currently focus on treatment, while survivorship care focuses on time after treatment. Cancer survivorship training represents an education paradigm shift.

Methods

The Cancer Survivorship Workshop was held at the James P. Wilmot Cancer Center of the University of Rochester in academic year 2011–2012, with six sessions held. Objectives included the following: learning about survivorship from patient, primary care physician, and oncologist perspectives using a curriculum based on survivorship literature; designing treatment summaries (TSs) and survivorship care plans (SCPs) for five malignancies (lung, breast, prostate, colon, and lymphoma); and establishing collaboration between hematology/oncology (HO) and radiation oncology (RO) trainees by working together in teams. Course impact was assessed pre- and post-training using a 13-question survey. Questions were answered using a 10-point scale, with predefined rating for each question.

Results

Statistically significant differences in responses to several survey questions were observed comparing pre- and post-course experience. Improvement was noted in comfort discussing survivorship issues with patients (p = 0.001), reported knowledge of survivorship care for five types of cancer (p = 0.002), confidence in ability to explain a SCP (p = 0.001), and comfort discussing late effects of cancer treatment (p = 0.001). Five unique sets of TS and SCPs were completed.

Conclusions

This study demonstrates the feasibility of implementing cancer survivorship education into the curriculum of HO and RO training.

Implications for Cancer Survivors

The project was designed with intension to optimize survivor care through enhanced provider training.
Literature
1.
go back to reference Siegel R, DeSantis C, Virgo K, et al. Cancer treatment and survivorship statistics, 2012. CA: A Cancer Journal for Clinicians. 2012;62:220–41. Siegel R, DeSantis C, Virgo K, et al. Cancer treatment and survivorship statistics, 2012. CA: A Cancer Journal for Clinicians. 2012;62:220–41.
2.
go back to reference Hewitt M, Greenfield S, Stovall E, editors. From cancer patient to cancer survivor: lost in transition. Washington: Institute of Medicine and National Research Council of the National Academies, National Academies; 2005. Hewitt M, Greenfield S, Stovall E, editors. From cancer patient to cancer survivor: lost in transition. Washington: Institute of Medicine and National Research Council of the National Academies, National Academies; 2005.
3.
go back to reference American College of Surgeons Commission on Cancer. Cancer program standard 2012: ensuring patient-centered care. Chicago: American College of Surgeons; 2011. American College of Surgeons Commission on Cancer. Cancer program standard 2012: ensuring patient-centered care. Chicago: American College of Surgeons; 2011.
5.
go back to reference Salz T, Oeffinger K, McCabe M, et al. Survivorship care plans in research and practice. CA: A Cancer Journal for Clinicians. 2012;62:101–17. Salz T, Oeffinger K, McCabe M, et al. Survivorship care plans in research and practice. CA: A Cancer Journal for Clinicians. 2012;62:101–17.
6.
go back to reference Grunfeld E, Julian J, Pond G, et al. Evaluating survivorship care plans: results of a randomized, clinical trial of patients with breast cancer. J Clin Oncol. 2011;29:4755–62.CrossRefPubMed Grunfeld E, Julian J, Pond G, et al. Evaluating survivorship care plans: results of a randomized, clinical trial of patients with breast cancer. J Clin Oncol. 2011;29:4755–62.CrossRefPubMed
7.
go back to reference Bober SL, Recklitis CJ, Campbell EG, et al. Caring for cancer survivors. Cancer. 2009;115:4409–18.CrossRefPubMed Bober SL, Recklitis CJ, Campbell EG, et al. Caring for cancer survivors. Cancer. 2009;115:4409–18.CrossRefPubMed
8.
9.
go back to reference Khatcheressian JL, Wolff AC, Smith TJ, et al. American Society of Clinical Oncology 2006 update of the breast cancer follow-up and management guidelines in the adjuvant setting. J Clin Oncol. 2006;24:5091–9097.CrossRefPubMed Khatcheressian JL, Wolff AC, Smith TJ, et al. American Society of Clinical Oncology 2006 update of the breast cancer follow-up and management guidelines in the adjuvant setting. J Clin Oncol. 2006;24:5091–9097.CrossRefPubMed
10.
go back to reference Desch CE, Benson III AB, Somerfield MR, et al. Colorectal cancer surveillance: 2005 update of an American Society of Clinical Oncology practice guideline. J Clin Oncol. 2005;23:8512–9.CrossRefPubMed Desch CE, Benson III AB, Somerfield MR, et al. Colorectal cancer surveillance: 2005 update of an American Society of Clinical Oncology practice guideline. J Clin Oncol. 2005;23:8512–9.CrossRefPubMed
11.
go back to reference Earle CC, Ganz PA. Cancer survivorship care: don't let the perfect be the enemy of the good. J Clin Oncol. 2012;30:3764–8.CrossRefPubMed Earle CC, Ganz PA. Cancer survivorship care: don't let the perfect be the enemy of the good. J Clin Oncol. 2012;30:3764–8.CrossRefPubMed
12.
go back to reference Landier W, Bhatia S, Eshelman D, et al. Development of risk based guidelines for pediatric cancer survivors: the Children's Oncology Group Long-term Follow-up Guidelines from the Children's Oncology Group Late Effects Committee and Nursing Discipline. J Clin Oncol. 2004;22:4979–90.CrossRefPubMed Landier W, Bhatia S, Eshelman D, et al. Development of risk based guidelines for pediatric cancer survivors: the Children's Oncology Group Long-term Follow-up Guidelines from the Children's Oncology Group Late Effects Committee and Nursing Discipline. J Clin Oncol. 2004;22:4979–90.CrossRefPubMed
13.
go back to reference Sullivan G. Deconstructing quality in education research. J Grad Med Edu. 2011;3:121–4.CrossRef Sullivan G. Deconstructing quality in education research. J Grad Med Edu. 2011;3:121–4.CrossRef
14.
go back to reference Kirkpatrick D. Revisiting Kirkpatrick's four-level model. Training and Development. 1996;50:455–64. Kirkpatrick D. Revisiting Kirkpatrick's four-level model. Training and Development. 1996;50:455–64.
15.
go back to reference Littlewood S, Ypinazar V, Margois S, et al. Early practical experience and the social responsiveness of clinical education: systematic review. BMJ. 2005;7513:387–91.CrossRef Littlewood S, Ypinazar V, Margois S, et al. Early practical experience and the social responsiveness of clinical education: systematic review. BMJ. 2005;7513:387–91.CrossRef
16.
go back to reference Reed D, Cook D, Beckman T, et al. Association between funding and quality of published medical education research. JAMA. 2007;298:1002–9.CrossRefPubMed Reed D, Cook D, Beckman T, et al. Association between funding and quality of published medical education research. JAMA. 2007;298:1002–9.CrossRefPubMed
17.
go back to reference Reed D, Beckman T, Wright S, et al. Predictive validity evidence for medical education research study quality instrument scores: quality of submission to JGIM's medical education special issue. J Gen Intern Med. 2008;23:903–7.PubMedCentralCrossRefPubMed Reed D, Beckman T, Wright S, et al. Predictive validity evidence for medical education research study quality instrument scores: quality of submission to JGIM's medical education special issue. J Gen Intern Med. 2008;23:903–7.PubMedCentralCrossRefPubMed
Metadata
Title
The integration of cancer survivorship training in the curriculum of hematology/oncology fellows and radiation oncology residents
Authors
Michelle Shayne
Eva Culakova
Michael T. Milano
Sughosh Dhakal
Louis S. Constine
Publication date
01-06-2014
Publisher
Springer US
Published in
Journal of Cancer Survivorship / Issue 2/2014
Print ISSN: 1932-2259
Electronic ISSN: 1932-2267
DOI
https://doi.org/10.1007/s11764-013-0328-0

Other articles of this Issue 2/2014

Journal of Cancer Survivorship 2/2014 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine